Outcome of obesity related comorbidities following laparoscopic adjustable gastric banding: a two-year prospective study
Παρουσιάστηκε στο 12th Congress of IFSO, Porto, Portugal 5-8 Sept 2007
Background: Obesity is often associated with comorbidities that require medical treatment. The aim of this study was to assess the effect of gastric banding on obesity-related comorbidities two years postoperatively.
Methods: Two hundred morbidly obese patients (mean age: 35 years old, mean preoperative BMI: 44 kg/m2) underwent laparoscopic adjustable gastric banding using the Helioscopie band (Heliogast® HAGE). One or more comorbidities were reported in 60 patients (30%). Hypertension (11%), diabetes (8%), fatty liver (4%), hyperlipidemia (3%), gastroesophageal reflux disease (3%), sleep apnea (3%) and osteoarthritis (3%) were the most common comorbidities. Patients were followed up to 24 months and the status of comorbidities was assessed before surgery and at the end of follow up.
Results: At 24 months mean %EWL was 65%. Complications were as follows: slippage 3%, band leakage 1%, gastric erosion 0.5%. All these complications were managed laparoscopically with band repositioning. Resolution of comorbidities was seen in 100% of patients having fatty liver, 100% with sleep apnea, 100% with reflux, 75% with diabetes, 66% with hyperlipidemia and 63% with hypertension.
Conclusion: Gastric banding is an effective weight loss operation with few complications. The majority of the patients are free of their obesity-related comorbidities two years postoperatively.
MEDIA
DIGITAL MEDIA STUDIO
